白杨素磷脂复合物固体分散体的制备及其体内药动学研究  被引量:4

Preparation and in vivo pharmacokinetics of solid dispersions of chrysin phospholipids complex

在线阅读下载全文

作  者:庞榕[1] 李开言[2] 王聪颖[1] PANG Rong;LI Kai-yan;WANG Cong-ying(College of Medicine,Huanghe Science&Technology College,Zhengzhou 450005,China;Henan Provincial Academy of Traditional Chinese Medicine,Zhengzhou 450004,China)

机构地区:[1]黄河科技学院医学院,河南郑州450005 [2]河南省中医药研究院,河南郑州450004

出  处:《中成药》2021年第10期2611-2615,共5页Chinese Traditional Patent Medicine

基  金:河南省科技攻关计划(201702031)。

摘  要:目的制备白杨素磷脂复合物固体分散体,并考察其体内药动学。方法溶剂挥发法制备固体分散体,测定体外溶出、表观溶解度,采用XRPD进行晶型分析。大鼠灌胃给药(20 mg/kg)后,于0.167、0.5、1、1.5、2、2.5、3、4、8、12 h采血,HPLC法测定白杨素血药浓度,计算主要药动学参数。结果药载比(磷脂复合物-PVP K30)为1∶6时,固体分散体240 min内累积溶出度达94.6%。白杨素在固体分散体中以无定型状态存在。与原料药、磷脂复合物比较,固体分散体在水、正辛醇中的表观溶解度升高(P<0.01),tmax缩短(P<0.05),Cmax、AUC0~t、AUC0~∞升高(P<0.01),相对生物利用度增加至2.16倍。结论固体分散体可改善白杨素磷脂复合物的体外溶出度和体内生物利用度。AIM To prepare the solid dispersions of chrysin phospholipids complex and to investigate their in vivo pharmacokinetics.METHODS Solvent evaporation method was adopted in the preparation of solid dispersions, after which the in vitro dissolution and apparent solubility were determined, and XRPD was applied to analyzing crystalline form. Rats were given intragastric administration(20 mg/kg), then blood collection was made at 0.167, 0.5, 1, 1.5, 2, 2.5, 3, 4, 8, 12 h, HPLC was adopted in the plasma concentration determination of chrysin, and main pharmacokinetic parameters were calculated.RESULTS At the drug-carrier ratio(phospholipids complex-PVP K30) of 1∶6, the accumulative dissolution rate of solid dispersions reached 94.6%. Chrysin existed in an amorphous state in the solid dispersions. Compared with the raw medicine and phospholipids complex, the solid dispersions demonstrated increased apparent solubilities in water and n-octanol(P<0.01), along with shortened tmax (P<0.05) and elevated Cmax, AUC0-t, AUC0-∞(P<0.01), the relative bioavailability was enhanced to 2.16 times.CONCLUSION Solid dispersions can improve the in vitro dissolution rate and in vivo bioavailability of chrysin phospholipids complex.

关 键 词:白杨素 磷脂复合物 固体分散体 制备 体内药动学 溶剂挥发法 XRPD HPLC 

分 类 号:R944[医药卫生—药剂学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象